MAPT and Cognitive impairment: Our findings suggest that (-)-SCR1693 exhibits beneficial effects on CCH-induced cognitive and memory deficits and that its effects on these cognitive deficits are mediated by attenuating CCH-induced dysfunction of the central cholinergic system and the tau protein in the brain.